602
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Solubility of Guaifenesin in the Presence of Common Pharmaceutical Additives

, , &
Pages 385-396 | Received 03 Jan 2003, Accepted 24 Mar 2003, Published online: 18 Sep 2003

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jayanti Nerurkar, J. W. Beach, M. O. Park & H. W. Jun. (2005) Solubility of ( ± )-Ibuprofen and S ( + )-Ibuprofen in the Presence of Cosolvents and Cyclodextrins. Pharmaceutical Development and Technology 10:3, pages 413-421.
Read now

Articles from other publishers (13)

Zhiying Pan, Yan Wang, Yang Xie, Jie Tan, Qian Zhang, Jianxing Lu, Shichao Du & Fumin Xue. (2023) Solubility and Crystallization of Glucosamine Hydrochloride in Water with the Presence of Additives. Crystals 13:9, pages 1326.
Crossref
Masoud Sadeghi, Francesca Cascella, Vico Tenberg, Andreas Seidel-Morgenstern & Heike Lorenz. (2021) Solubility analysis of pharmaceuticals guaifenesin, ketoprofen, and artemisinin in different solvents. Journal of Molecular Liquids 343, pages 117503.
Crossref
Mohammed R. Elamin, Amin O. Elzupir & Babiker Y. Abdulkhair. (2021) Synthesis and characterization of functionalized carbon nanofibers for efficient removal of highly water-soluble dextromethorphan and guaifenesin from environmental water samples. Environmental Nanotechnology, Monitoring & Management 15, pages 100397.
Crossref
Francesca Cascella, Erik Temmel, Andreas Seidel-Morgenstern & Heike Lorenz. (2019) Efficient Resolution of Racemic Guaifenesin via Batch-Preferential Crystallization Processes. Organic Process Research & Development 24:1, pages 50-58.
Crossref
A. M. Kolbach-Mandel, N. S. Mandel, S. R. Cohen, J. G. Kleinman, F. Ahmed, I. C. Mandel & J. A. Wesson. (2016) Guaifenesin stone matrix proteomics: a protocol for identifying proteins critical to stone formation. Urolithiasis 45:2, pages 139-149.
Crossref
Robert R. Fayzullin, Heike Lorenz, Zemfira A. Bredikhina, Alexander A. Bredikhin & Andreas Seidel-Morgenstern. (2014) Solubility and Some Crystallization Properties of Conglomerate Forming Chiral Drug Guaifenesin in Water. Journal of Pharmaceutical Sciences 103:10, pages 3176-3182.
Crossref
Caroline Bruce, Kurt A. Fegely, Ali R. Rajabi-Siahboomi & James W. McGinity. (2007) Crystal growth formation in melt extrudates. International Journal of Pharmaceutics 341:1-2, pages 162-172.
Crossref
Chengsheng Liu, Kashappa Goud H. Desai, Xuexi Tang & Xiguang Chen. (2005) Solubility of Rofecoxib in the Presence of Aqueous Solutions of Glycerol, Propylene Glycol, Ethanol, Span 20, Tween 80, and Sodium Lauryl Sulfate at (298.15, 303.15, and 308.15) K. Journal of Chemical & Engineering Data 50:6, pages 2061-2064.
Crossref
Chengsheng Liu, Kashappa Goud H. Desai, Xiguang Chen & Xuexi Tang. (2005) Solubility of Valdecoxib in the Presence of Glycerol, Propylene Glycol, and Poly(ethylene glycol) 400 at (298.15, 303.15, and 308.15) K. Journal of Chemical & Engineering Data 50:5, pages 1736-1739.
Crossref
Chengsheng Liu, Kashappa Goud H. Desai & Chenguang Liu. (2005) Solubility of Rofecoxib in the Presence of Mannitol, Poly(vinylpyrrolidone) K30, Urea, Polyethylene Glycol 4000, and Polyethylene Glycol 6000 at (298.15, 303.15, and 308.15) K. Journal of Chemical & Engineering Data 50:2, pages 661-665.
Crossref
Chenguang Liu, Kashappa Goud H. Desai & Chengsheng Liu. (2004) Solubility of Valdecoxib in the Presence of Poly(ethylene glycol) 4000, Poly(ethylene glycol) 6000, Poly(ethylene glycol) 8000, and Poly(ethylene glycol) 10 000 at (298.15, 303.15, and 308.15) K. Journal of Chemical & Engineering Data 50:1, pages 278-282.
Crossref
Chengsheng Liu, Kashappa Goud H. Desai & Chenguang Liu. (2004) Solubility of Valdecoxib in the Presence of Ethanol and Sodium Lauryl Sulfate at (298.15, 303.15, and 308.15) K. Journal of Chemical & Engineering Data 49:6, pages 1847-1850.
Crossref
Kashappa Goud H. Desai & Hyun J. Park. (2004) Solubility studies on valdecoxib in the presence of carriers, cosolvents, and surfactants. Drug Development Research 62:1, pages 41-48.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.